Risk of cardiovascular events associated with dipeptidyl peptidase-4 inhibitors in patients with diabetes with and without chronic kidney disease: A nationwide cohort study

BACKGROUND: Cardiovascular events associated with oral hypoglycemic agents (OHAs) have raised significant safety concerns. This study assessed the association between dipeptidyl peptidase-4 inhibitors (DPP-4i) and the risk of cardiovascular events in patients with type 2 diabetes mellitus with or wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Tzu-Lan, Hsiao, Fei-Yuan, Chiang, Chih-Kang, Shen, Li-Jiuan, Huang, Chih-Fen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528980/
https://www.ncbi.nlm.nih.gov/pubmed/31112536
http://dx.doi.org/10.1371/journal.pone.0215248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528980/
https://www.ncbi.nlm.nih.gov/pubmed/31112536
http://dx.doi.org/10.1371/journal.pone.0215248

Ejemplares similares